Cynbiose will attend the 3rd workshop on Probiotics and Gut Microbiotia - Lyon, February 4th 2020

Key event organized by Lyonbiopole, the “Probiotics and Intestinal Microbiota Day” brings together academic, clinical and industrial players (SMEs and large groups), around a thematic lecture on the modulation of the intestinal microbiota. For this 3rd edition, the central theme "Yesterday's antibiotics, next-generation probiotics and other new strategies for modulating the intestinal microbiota" will provide an opportunity to highlight product developments and their future challenges. Contact us to meet our team during this day.  

guillemets gauche Supporting Biomedical Research guillemets droit

Cynbiose is a preclinical Contract Research Organization (CRO) unique in Europe. The company develops and commercializes innovative non human primate (NHP) models to accelerate the preclinical development of drug candidates.

We perform exploratory studies and develop pharmacological models in the main therapeutic areas to bridge the gap between preclinical phase and clinical development.

We provide high value-added services in a quality-based environment and work closely with our customers to achieve long-term relationships.